MediPoint: Central Vascular Access Devices - Global Analysis and Market Forecasts
Summary
Central vascular devices, particularly catheters, have been a mainstay of modern medicine for the last 40 years. These devices are intended for patients with both acute and chronic diseases such as systemic infections, which require catheters that are able to be situated comfortably and confidently within a patient’s venous system for extended periods of time.
The report analyses the market at a category (PICC, Non-tunneled, tunneled, port, hemodialysis catheters and Huber needles) and subcategory level (E.G. antimicrobial vs non-antimicrobial and acute vs chronic hemodialysis catheters) highlighting trends and issues affecting utilization, volume and value of central access devices at a country level.
Key topics discussed include the increasing utilization of PICCs thanks to the development of nurse led implantations and the reasons for the slow adoption of antimicrobial technologies within major markets.
Highlights
Key Questions Answered
- What is the current and future outlook of the central vascular access devices in developed and emerging markets?
- What are unmet needs in the central vascular access devices market? What are the clinical and non-clinical barriers in this space? What is hampering innovation within this market?
- What trends are affecting the global central vascular access devices market?
Scope
- Competitive assessment: Currently marketed central vascular access devices products and evolving competitive landscape
- In-depth analysis of practice patterns and adoption trends of different segments and sub-segments of central vascular access devices
- Insightful review of the key industry drivers, opportunities, restraints and challenges. Each trend is independently researched to provide qualitative analysis of its implications
- Other key topics covered include utilization trends, market access, reimbursement considerations, and implications for the overall market
- Market share analysis of the competition in different regions
- Annualized Individual and cumulative sales units and market revenues for the PICC (Antimicrobial vs Non-antimicrobial), Non-tunneled (Antimicrobial vs Non-antimicrobial), Tunneled, Implantable Ports, Hemodialysis catheters (Chronic vs Acute) and Huber needles market from 2012-2022
Reasons to buy
The report will enable you to -
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline
- Develop business strategies by understanding the trends shaping and driving the global market
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analysing the performance of various competitors
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Track device sales in the global market from 2012-2022
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships
Table Of Contents
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 10
1.2 List of Figures 14
2 Introduction 17
2.1 Catalyst 18
3 Industry Overview 19
3.1 Central Venous Catheters 19
3.1.1 Peripherally Inserted Central Catheter 19
3.1.2 Non-tunneled Catheters 20
3.1.3 Tunneled Catheters 21
3.1.4 Implantable Ports 21
3.1.5 Hemodialysis Catheters 23
3.2 Technological Assessment 26
3.3 Mergers, Acquisitions, and Key Partnerships 27
4 Market Access 29
4.1 Reimbursement 29
4.1.1 North America and Brazil 29
4.1.2 5EU 30
4.1.3 Asia-Pacific 34
4.2 Regulatory Issues/Recalls 37
5 Unmet Needs 38
5.1 Catheter Related Complications 38
5.1.1 Catheter Related Infections 38
5.1.2 Catheter Related Thrombosis 38
5.1.3 Other Complications: Arrhythmia, Phlebitis, and Venous Air Embolism 39
5.2 Expansion of Non-physician Led Central Vascular Catheter Placement 40
5.3 Lack of Devices For Pediatric Populations 41
6 Competitive Assessment 42
6.1 Company Share Analysis 42
6.1.1 Global Central Vascular Catheter Devices Market Share 42
6.1.2 Global Acute Central Vascular Catheter Devices (Non-tunneled) Market Share 43
6.1.3 Global Peripherally Inserted Central Catheter Market Share 43
6.1.4 Global Hemodialysis Catheter Market Share 44
6.2 Peripherally Inserted Central Catheters (Antimicrobial and Non-antimicrobial) 44
6.2.1 Overview 44
6.3 Non-tunneled Catheters (Antimicrobial and Non-antimicrobial) 47
6.3.1 Overview 47
6.4 Tunneled Catheters 49
6.4.1 Overview 49
6.5 Implantable Ports and Huber Needles 51
6.5.1 Overview 51
6.6 Chronic and Acute Hemodialysis Catheters 56
6.6.1 Overview 56
7 Company Profiles 63
7.1 Overview 63
7.2 AngioDynamics 63
7.2.1 Overview 63
7.2.2 Marketed Products Assessment 64
7.2.3 SWOT Analysis 65
7.3 Argon Medical Devices 65
7.3.1 Overview 65
7.3.2 Marketed Products Assessment 66
7.3.3 SWOT Analysis 67
7.4 B. Braun Melsungen AG 67
7.4.1 Overview 67
7.4.2 Market Products Assessment 68
7.4.3 SWOT Analysis 69
7.5 Cook Medical 70
7.5.1 Overview 70
7.5.2 Marketed Products Assessment 70
7.5.3 SWOT Analysis 71
7.6 Covidien (Medtronic) 72
7.6.1 Overview 72
7.6.2 Marketed Products Assessment 72
7.6.3 SWOT Analysis 73
7.7 C. R. Bard 73
7.7.1 Overview 73
7.7.2 Marketed Products Assessment 74
7.7.3 SWOT Analysis 76
7.8 Edwards 76
7.8.1 Overview 76
7.8.2 Marketed Products Assessment 77
7.8.3 SWOT Analysis 78
7.9 Gambro 78
7.9.1 Overview 78
7.9.2 Marketed Product Assessment 78
7.9.3 SWOT Analysis 79
7.10 Medcomp 80
7.10.1 Overview 80
7.10.2 Marketed Product Assessment 80
7.10.3 SWOT Analysis 81
7.11 Navilyst Medical 82
7.11.1 Overview 82
7.11.2 Marketed Products Assessment 82
7.11.3 SWOT Analysis 83
7.12 Perouse Medical 84
7.12.1 Overview 84
7.12.2 Marketed Products Assessment 84
7.12.3 SWOT Analysis 85
7.13 Smiths Medical 85
7.13.1 Overview 85
7.13.2 Marketed Products Assessment 86
7.13.3 SWOT Analysis 87
7.14 Teleflex 87
7.14.1 Overview 87
7.14.2 Marketed Products Assessment 88
7.14.3 SWOT Analysis 89
7.15 Vygon 89
7.15.1 Overview 89
7.15.2 Marketed Products Assessment 90
7.15.3 SWOT Analysis 91
7.16 Other Companies 92
8 Market Outlook 93
8.1 Procedure Trends 93
8.1.1 Global Central Vascular Catheter Procedures 93
8.1.2 Global Hemodialysis Patients (New and Existing) 95
8.2 Market Drivers and Barriers 98
8.2.1 Driver: Growing Global Population and Growing Aging Population 98
8.2.2 Driver: Increasing Financial Power of Developing Countries 99
8.2.3 Driver: Increasing Burden of Chronic Conditions 99
8.2.4 Driver: Nurse-Led Peripherally Inserted Central Catheter Placement 100
8.2.5 Driver: Central Vascular Catheter Placement Protocols 100
8.2.6 Driver: Technological Advances 101
8.2.7 Driver: Interventional Radiology 102
8.2.8 Barrier: Safety Concerns and Product Recalls 102
8.2.9 Barrier: Clinical Evidence 103
8.2.10 Barrier: Healthcare Cost-Cutting 103
8.2.11 Barrier: Medical Device Excise Tax 104
8.3 Market Outlook by Segment 104
8.3.1 Global Central Vascular Catheter Devices Market 104
8.3.2 Global Central Vascular Catheter Devices Market Value by Segment 107
8.3.3 Global Peripherally Inserted Central Catheter Sub-segment Market Value 109
8.3.4 Global Non-tunneled Catheters Sub-segment Market Value 111
8.3.5 Global Hemodialysis Catheters Sub-segment Market Value 113
8.4 Market Outlook by Geography 115
8.4.1 US 115
8.4.2 France 119
8.4.3 Germany 123
8.4.4 Italy 127
8.4.5 Spain 131
8.4.6 UK 136
8.4.7 Japan 140
8.4.8 China 144
8.4.9 India 148
8.4.10 Brazil 152
9 Appendix 156
9.1 Bibliography 156
9.2 Abbreviations 163
9.3 Methodology 167
9.3.1 Overview 167
9.3.2 Coverage 167
9.3.3 Secondary Research 167
9.4 Forecasting Methodology 169
9.5 Primary Research Efforts 169
9.5.1 Physician Survey 169
9.6 About the Authors 170
9.6.1 Amen Sanghera, Analyst, Medical Devices (Author) 170
9.6.2 Linda Tian, Managing Analyst, Research and Analysis, Medical Devices 170
9.6.3 Tyler Fletcher, Global Head of Medical Devices 171
9.7 About GlobalData 172
9.8 Disclaimer 172
List Of Tables
1.1 List of Tables
Table 1: Overview of Vascular Access Devices, 2016 17
Table 2: Indications for HD catheter placement 23
Table 3: Advantages and Disadvantages of CVC Devices 24
Table 4: Technology used with CVC catheters 26
Table 5: Mergers, Acquisitions, and Key Partnerships, 2012-2016 28
Table 6: North America and Brazil’s Reimbursement Agencies 29
Table 7: 5EU Reimbursement Agencies 30
Table 8: APAC Reimbursement Agencies 34
Table 9: Product Recalls, 2014-2016 37
Table 10: Marketed PICC Products 45
Table 11: Marketed Non-tunneled Catheter Products 48
Table 12: Marketed Tunneled Catheter Products 50
Table 13: Marketed Implantable Ports 52
Table 14: Marketed Huber Needles 55
Table 15: Marketed Acute HD Catheters 57
Table 16: Marketed Chronic HD Catheters 59
Table 17: Company Profile - AngioDynamics 63
Table 18: AngioDynamics’ Marketed CVCs 64
Table 19: SWOT Analysis - AngioDynamics 65
Table 20: Company Profile - Argon Medical Devices 66
Table 21: Argon Medical’s Marketed CVC Devices 66
Table 22: SWOT Analysis - Argon Medical Devices 67
Table 23: Company Profile - B. Braun 68
Table 24: B. Braun Marketed CVCs 69
Table 25: SWOT Analysis - B. Braun 69
Table 26: Company Profile - Cook Medical 70
Table 27: Cook Medical Marketed CVCs 71
Table 28: SWOT Analysis - Cook Medical 71
Table 29: Company Profile - Covidien 72
Table 30: Covidien Marketed CVCs 72
Table 31: SWOT Analysis - Covidien 73
Table 32: Company Profile - C. R. Bard 74
Table 33: C. R. Bard Marketed CVCs 75
Table 34: SWOT Analysis - C. R. Bard 76
Table 35: Company Profile - Edwards 77
Table 36: Edwards Marketed CVCs 77
Table 37: SWOT Analysis - Edwards 78
Table 38: Company Profile - C. R. Bard 78
Table 39: Gambro Marketed CVCs 79
Table 40: SWOT Analysis - Gambro 79
Table 41: Company Profile - Medcomp 80
Table 42: Medcomp Marketed CVCs 81
Table 43: SWOT Analysis - Medcomp 81
Table 44: Company Profile - Navilyst 82
Table 45: Navilyst Marketed CVCs 83
Table 46: SWOT Analysis - Navilyst 83
Table 47: Company Profile - Perouse Medical 84
Table 48: Perouse Medical Marketed CVCs 84
Table 49: SWOT Analysis - Perouse Medical 85
Table 50: Company Profile - Smiths Medical 86
Table 51: Smiths Medical Marketed CVCs 86
Table 52: SWOT Analysis - Smiths Medical 87
Table 53: Company Profile - Teleflex 88
Table 54: Teleflex Marketed CVCs 88
Table 55: SWOT Analysis - Teleflex 89
Table 56: Company Profile - Vygon 90
Table 57: Vygon Marketed CVCs 90
Table 58: SWOT Analysis - Vygon 91
Table 59: Other Companies Involved in the CVC Devices Market 92
Table 60: Global CVC Patient Procedures, 2012-2022 95
Table 61: Global HD Patients Receiving CVCs (New and Existing), 2012-2022 98
Table 62: Keystone ICU Project Checklist and Considerations 101
Table 63: Global CVC Devices Market Value ($m), 2012-2022 107
Table 64: Global CVC Devices Market Value ($m), by Segment, 2012-2022 109
Table 65: Global PICC Market Value ($m), by Sub-segment, 2012-2022 111
Table 66: Global Non-tunneled Catheters Market Value ($m), by Sub-segment, 2012-2022 113
Table 67: Global HD Catheters Market Value ($m), by Sub-segment, 2012-2022 114
Table 68: US CVC Devices Market Value ($m), by Segment, 2012-2022 116
Table 69: France CVC Devices Market Value ($m), by Segment, 2012-2022 120
Table 70: Germany CVC Devices Market Value ($m), by Segment, 2012-2022 124
Table 71: Italy CVC Devices Market Value ($m), by Segment, 2012-2022 128
Table 72: Spain CVC Devices Market Value ($m), by Segment, 2012-2022 132
Table 73: UK CVC Devices Market Value ($m), by Segment, 2012-2022 137
Table 74: Japan CVC Devices Market Value ($m), by Segment, 2012-2022 141
Table 75: China CVC Devices Market Value ($m), by Segment, 2012-2022 145
Table 76: India CVC Devices Market Value ($m), by Segment, 2012-2022 149
Table 77: Brazil CVC Devices Market Value ($m), by Segment, 2012-2022 153
Table 78: Physicians Surveyed, By Country 169
List Of Figures
1.2 List of Figures
Figure 1: PICC Line Overview 20
Figure 2: Non-tunneled Catheter Overview 20
Figure 3: Tunneled Catheter Overview 21
Figure 4: Implantable Port Overview 22
Figure 5: Huber Needle Overview 22
Figure 6: Global CVC Devices Market Share, 2015 42
Figure 7: Global Acute CVC Market Share, 2015 43
Figure 8: Global PICC Devices Market Share, 2015 43
Figure 9: Global HD Catheters Market Share, 2015 44
Figure 10: Global CVC Patient Procedures, 2012-2022 93
Figure 11: Global CVC Patient Procedures, by Country, 2012-2022 94
Figure 12: Global CVC Patient Procedures, Breakdown by Country, 2015 and 2022 94
Figure 13: Global HD Patients Receiving CVCs (New and Existing), 2012-2022 96
Figure 14: Global HD Patients Receiving CVCs (New and Existing), by Country, 2012-2022 96
Figure 15: Global HD Patients Receiving CVCs (New and Existing), Breakdown by Country, 2015 and 2022 97
Figure 16: Global CVC Devices Market Value ($m), 2012-2022 105
Figure 17: Global CVC Devices Market Value, Percentage Breakdown, by Country, 2015 and 2022 106
Figure 18: Global CVC Devices Market Value ($m) by Segment, 2012-2022 108
Figure 19: Global CVC Devices Market Value , Percentage Breakdown by Segment, 2012 and 2015 108
Figure 20: Global PICC Market Value ($m) by Sub-segment, 2012-2022 110
Figure 21: Global PICC Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022 110
Figure 22: Global Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 112
Figure 23: Global Non-tunneled Catheters Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022 112
Figure 24: Global HD Catheters Market Value ($m) by Sub-segment, 2012-2022 113
Figure 25: Global HD Catheters Market Value, Percentage Breakdown, by Sub-segment, 2015 and 2022 114
Figure 26: US CVC Devices Market Value ($m) by Segment, 2012-2022 115
Figure 27: US PICC Market Value ($m) by Sub-segment, 2012-2022 117
Figure 28: US Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 118
Figure 29: US HD Catheters Market Value ($m) by Sub-segment, 2012-2022 119
Figure 30: France CVC Devices Market Value ($m) by Segment, 2012-2022 120
Figure 31: France PICC Market Value ($m) by Sub-segment, 2012-2022 121
Figure 32: France Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 122
Figure 33: France HD Catheters Market Value ($m) by Sub-segment, 2012-2022 123
Figure 34: Germany CVC Devices Market Value ($m) by Segment, 2012-2022 124
Figure 35: Germany PICC Market Value ($m) by Sub-segment, 2012-2022 125
Figure 36: Germany Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 126
Figure 37: Germany HD Catheters Market Value ($m) by Sub-segment, 2012-2022 127
Figure 38: Italy CVC Devices Market Value ($m) by Segment, 2012-2022 128
Figure 39: Italy PICC Market Value ($m) by Sub-segment, 2012-2022 129
Figure 40: Italy Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 130
Figure 41: Italy HD Catheters Market Value ($m) by Sub-segment, 2012-2022 131
Figure 42: Spain CVC Devices Market Value ($m) by Segment, 2012-2022 132
Figure 43: Spain PICC Market Value ($m) by Sub-segment, 2012-2022 133
Figure 44: Spain Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 134
Figure 45: Spain HD Catheters Market Value ($m) by Sub-segment, 2012-2022 135
Figure 46: UK CVC Devices Market Value ($m) by Segment, 2012-2022 136
Figure 47: UK PICC Market Value ($m) by Sub-segment, 2012-2022 138
Figure 48: UK Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 139
Figure 49: UK HD Catheters Market Value ($m) by Sub-segment, 2012-2022 140
Figure 50: Japan CVC Devices Market Value ($m) by Segment, 2012-2022 141
Figure 51: Japan PICC Market Value ($m) by Sub-segment, 2012-2022 142
Figure 52: Japan Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 143
Figure 53: Japan HD Catheters Market Value ($m) by Sub-segment, 2012-2022 144
Figure 54: China CVC Devices Market Value ($m) by Segment, 2012-2022 145
Figure 55: China PICC Market Value ($m) by Sub-segment, 2012-2022 146
Figure 56: China Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 147
Figure 57: China HD Catheters Market Value ($m) by Sub-segment, 2012-2022 148
Figure 58: India CVC Devices Market Value ($m) by Segment, 2012-2022 149
Figure 59: India PICC Market Value ($m) by Sub-segment, 2012-2022 150
Figure 60: India Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 151
Figure 61: India HD Catheters Market Value ($m) by Sub-segment, 2012-2022 152
Figure 62: Brazil CVC Devices Market Value ($m) by Segment, 2012-2022 153
Figure 63: Brazil PICC Market Value ($m) by Sub-segment, 2012-2022 154
Figure 64: Brazil Non-tunneled Catheters Market Value ($m) by Sub-segment, 2012-2022 154
Figure 65: Brazil HD Catheters Market Value ($m) by Sub-segment, 2012-2022 155
